Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1

Clinical Cancer Research

Volumn 5, Issue 9, 1999, Pages 2646-2652

  Archer, Gary E ^a   Sampson, John H ^a   Lorimer, Ian A J ^b   McLendon, Roger E ^a   Kuan, Chien Tsun ^d   Friedman, Allan H ^a   Friedman, Henry S ^a   Pastan, Ira H ^c   Bigner, Darell D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b OTTAWA REGIONAL CANCER CENTRE   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOTOXIN; INTERLEUKIN 2 RECEPTOR; PSEUDOMONAS EXOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CARCINOMATOUS MENINGITIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLIOBLASTOMA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIBODY SPECIFICITY; BACTERIAL TOXINS; EXOTOXINS; FEMALE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOTOXINS; INJECTIONS, SPINAL; MENINGEAL NEOPLASMS; MICE; MICE, NUDE; MUTATION; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED; VIRULENCE FACTORS;

EID: 0032881866     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Grossman, S. A., and Moynihan., T. J. Neoplastic meningitis. Neurol. Clin., 9: 843-856, 1991.
2. Hall, W. A., and Fodstad, O. Immunotoxins and central nervous system neoplasia. J. Neurosurg., 76: 1-12, 1992.
3. Pastan, I. H., Archer, G. E., McLendon, R. E., Friedman, H. S., Fuchs, H. E., Wang, Q. C., Pai, L. H., Herndon, J., and Bigner, D. D. Intrathecal administration of single-chain immunotoxin, LMB-7 {B3(Fv)-PE38}, produces cures of carcinomatous meningitis in a rat model. Proc. Natl. Acad. Sci. USA, 92: 2765-2769, 1995.
4. Humphrey, P. A., Wong, A. J., Vogelstein, B., Zalutsky, M. R., Fuller, G. N., Archer, G. E., Friedman, H. S., Kwatra, M. M., Bigner, S. H., and Bigner, D. D. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc. Natl. Acad. Sci. USA, 87: 4207-4211, 1990.
5. Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, L., Humphrey, P. A., Kurpad, S. N., McLendon, R. E., Moscatello, D., Pegram, C. N., Reist, C. J., Traweek, S. T., Wong, A. J., Zalutsky, M. R., and Bigner, D. D. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res., 55: 3140-3148, 1995.
6. Lorimer, I. A. J., Keppler-Hafkemeyer, A., Beers, R. A., Pegram, C. N., Bigner, D. D., and Pastan, I. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display. Proc. Natl. Acad. Sci. USA, 93: 14815-14820, 1996.
7. 125I-labeled anti-epidermal growth factor receptor-VIII single chain Fv exhibits specific and high-level targeting of glioma xenografts. Clin. Cancer Res., 5: 1539-1549, 1999.
8. Kreitman, R. J., Bailon, P., Chudhary, V. K., Fitzgerald, D. J. P., and Pastan, I. Recombinant immunotoxins containing anti-Tac (Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. Blood, 83: 426-434, 1994.
9. Kuan, C-T., Wang, Q-C., and Pastan, I. Pseudomonas exotoxin A mutants: replacement of surface exposed residues in domain II with cysteine residues that can be modified with PEG in a site-specific manner. J. Biol. Chem., 269: 7610-7616, 1994.
10. Nishikawa, R., Ji, X., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., and Su Huang, H. J. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA, 91: 7727-7731, 1994.
11. Wikstrand, C. J., McLendon, R. E., Friedman, A. H., and Bigner, D. D. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res., 57: 4130-4140, 1997.
12. Fuchs, H. E., Archer, G. E., Colvin, O. M., Bigner, S. H., Schuster, J. M., Muhlbaier, L. H., Schold, S. C., Jr., Friedman, H. S., and Bigner, D. D. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis. Cancer Res., 50: 1954-1959, 1990.
13. Kooistra, K. L., Rodriquez, M., Powis, G., Yaksh, T. L., Harty, G. J., Hilton, J. F., and Laws, E. R., Jr. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat. Cancer Res., 46: 317-323, 1986.
14. Schold, S. C., Friedman, H. S., and Bigner, D. D. Therapeutic profile of the human glioma line D-54 MG in athymic mice. Cancer Treat. Rep., 71: 849-850, 1987.
15. Olson, M. E., Chenik, N. L., and Posner, J. B. Infiltration of the leptomeninges by systemic cancer: a clinical and pathological study. Arch. Neurol., 30: 122-137, 1974.
16. Wasserstrom, W. R., Glass, J. P., and Posner, J. B. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer (Phila.), 49: 759-772, 1982.
17. Yamazki, H., Fukui, Y., Ueyama, Y., Tamaoki, N., Kawamoto, T., Taniguchi, S. Amplification of the structurally and functionally altered epidermal growth receptor gene (c-erbB) in human brain tumors. Mol. Cell. Biol., 8: 1816-1820, 1988.
18. Batra, S. K., Rasheed, B. K. A., Bigner, S. H., and Bigner, D. D. Oncogenes and anti-oncogenes in human central nervous system tumors. Lab. Investig., 71: 621-637, 1994.
19. Seeldrayers, P., and Hilderbrand, J. Treatment of neoplastic meningitis. Eur. J. Cancer Clin. Oncol., 20: 449-456, 1984.
20. Zovickian, V. G., and Youle, R. J. Efficacy of intrathecal immunotoxin therapy in an animal model of leptomeningeal neoplasia. J. Neurosurg., 70: 240-248, 1988.
21. Lorimer, I. A. J., Wikstrand, C. J., Batra, S. K., Bigner, D. D., and Pastan, I. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors. Clin. Cancer Res., 1: 859-864, 1995.
22. Bigner, D. D., Archer, G. E., McLendon, R. E., Friedman, H. S., Fuchs, H. E., Pai, L. H., Herndon, J. E., and Pastan, I. H. Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitis. Clin. Cancer Res., 1: 1545-1545, 1995.
23. Walbridge, S., and Rybak, S. M. Immunotoxin therapy of leptomeningeal neoplasia. J. Neuro-Oncol., 20: 59-65, 1994.